The role of microRNAs in heart failure

Hongjiang Wang1, Jun Cai2

  • 1Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Insights

MicroRNAs regulate gene expression and are crucial in cardiovascular diseases like heart failure. This review details their roles in heart failure pathologies, including angiogenesis, hypertrophy, fibrosis, and apoptosis.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Extensive research highlights miRNA involvement in cardiovascular diseases.
  • Heart failure pathogenesis is a significant area of investigation.

Purpose of the Study:

  • To review target genes and functionality of miRNAs in heart failure.
  • To categorize miRNAs based on their target genes' relevance to cardiovascular pathologies.
  • To provide an overview of miRNA roles in cardiovascular health and disease.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Focus on studies investigating miRNA target genes and function in heart failure.
  • Categorization of miRNAs by biological relevance to angiogenesis, cardiac hypertrophy, fibrosis, and apoptosis.

Main Results:

  • Identified specific miRNAs involved in key heart failure processes.
  • Demonstrated miRNA influence on angiogenesis, cardiac hypertrophy, fibrosis, and apoptosis.
  • Highlighted diverse biological signaling pathways regulated by miRNAs in heart failure.

Conclusions:

  • MicroRNAs play significant roles in the pathophysiology of heart failure.
  • Understanding miRNA functionality is key to developing novel therapeutic strategies for cardiovascular diseases.
  • This review consolidates current knowledge on miRNAs in cardiovascular health and disease.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K